Skip to main content

Table 1 Univariate logistical regression analysis

From: Development of a risk scoring system for prognostication in HIV-related toxoplasma encephalitis

Variable

Total

Death

Survival

p

OR (95%CI)

Age (years old):

94

  

0.570

1.510 (0.364, 6.256)

 <  40;

 

7;

51;

  

 ≥ 40

 

3

33

  

Gender:

94

  

0.259

3.393 (0.407, 28.297)

 Male;

 

9;

61;

  

 Female

 

1

23

  

Fever:

94

  

0.123

0.109 (0.636, 43.550)

 Yes;

 

1;

31;

  

 No

 

9

53

  

Dizziness:

94

  

0.136

0.500 (0.604, 41.392)

 Yes;

 

1;

30;

  

 No

 

9

54

  

Headache:

94

  

0.776

1.230 (0.296, 5.117)

 No;

 

3;

29;

  

 Yes

 

7

55

  

Vomiting:

94

  

0.732

1.286 (0.305, 5.426)

 No;

 

7;

63;

  

 Yes

 

3

21

  

Memory deficits:

94

  

0.030

4.500 (1.157, 17.500)

 No;

 

4;

63;

  

 Yes

 

6

21

  

Cognitive impairment:

94

  

0.133

3.950 (0.657, 23.749)

 No;

 

8;

79;

  

 Yes

 

2

5

  

Disorders of consciousness:

94

  

0.005

7.400 (1.817, 30.144)

 No;

 

5;

74;

  

 Yes

 

5

10

  

Dysphasia:

94

  

0.008

6.375 (1.608, 25.274)

 No;

 

4;

68;

  

 Yes

 

6

16

  

Meningeal irritation signs:

94

  

0.053

6.750 (0.979, 46.551)

 No;

 

8;

81;

  

 Yes

 

2

3

  

Time from symptom onset to presentation:

94

  

0.193

2.567 (0.621, 10.604)

 < 15 days;

 

3;

44;

  

 ≥15 days

 

7

40

  

ART initiation:

94

  

0.421

1.731 (0.455, 6.582)

 No;

 

4;

45;

  

 Yes

 

6

39

  

CD4+ T-cell counts:

94

  

0.005

7.982 (1.880, 33.890)

 ≥ 25 cells/μL;

 

3;

65;

  

 <  25 cells/μL

 

7

19

  

Patchy lesions on MRI:

94

  

0.192

2.437 (0.639, 9.305)

 No;

 

4;

52;

  

 Yes

 

6

32

  

Ring-enhancing lesions on MRI:

94

  

0.790

0.833 (0.218, 3.188)

 No;

 

4;

30;

  

 Yes

 

6

54